Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
Redx Pharma’s Merger with Jounce Therapeutics
ThoughtFocus’ Acquisition of BreakFree
Foley & Lardner LLP represented BreakFree Solutions on the deal. BreakFree Solutions, LLC (BreakFree) announced its recent acquisition by ThoughtFocus, Inc. (ThoughtFocus), a global provider of digital...
Alteryx’s $450 Million Senior Notes Offering
Wilson Sonsini advised Alteryx on the deal. Alteryx, Inc. announced that it has priced its offering of $450 million aggregate principal amount of its 8.75 percent...
Bicara Therapeutics’ $108 Million Series B Financing
Goodwin Procter advised Bicara Therapeutics on the deal. Bicara Therapeutics announced the completion of its oversubscribed $108 million Series B financing to advance the company’s lead program...
Rapport Therapeutics’ $100 Million Series A Financing
Goodwin Procter advised Rapport Therapeutics, Inc. on the deal. Rapport Therapeutics, Inc. announced its launch with a $100 million Series A financing from Third Rock Ventures, ARCH...
Dogado’s Acquisition of Cionix’s Hosting Services
Goodwin advised Cionix GmbH on the deal. Cionix GmbH (“cionix”) announced the sale of its hosting business to dogado GmbH (“dogado”). Dogado is a leading provider of...
Vast’s Acquisition of Launcher
Fenwick represented Vast on the deal. Vast, a developer of space habitation technologies focused on expanding humanity across the solar system, announced its acquisition of Launcher, a...
Vitally’s $30 Million Series B Financing
Fenwick represented Vitally on the deal. Vitally, a customer success productivity (CSP) platform, announced its $30 million Series B financing. The round was led byNext47, with participation...
Cisco’s Acquisition of Valtix
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Valtix, a privately...
IBM’s Acquisition of NS1
Fenwick advised NS1 on the deal. NS1, a provider of network automation SaaS solutions that are designed to enable businesses to deliver content, services and applications...
EngageSmart’s Public Offering
Latham & Watkins advised EngageSmart, Fenwick & West advised the underwriters, Paul Weiss, Kirkland & Ellis LLP, Maples and Calder (Cayman) and Whalen, respectively, advised certain...
VerAI’s $12 Million Series A Funding Round
Fenwick represented VerAI on the deal. VerAI, an AI-powered mineral discovery technology company, announced its $12 million Series A funding round, including funds and accounts advised by...